Shares increase as the US FDA approves Novavax’s revised COVID injection.
The modified COVID-19 vaccine from Novavax has been approved by the U.S. Food and Drug Administration for use in emergency situations in people 12 years of age and older, the agency announced on Tuesday. Shares of Novavax increased 12% to $7.95. The Maryland-based company, which only has the updated COVID vaccination on the market, has … Read more